Insurance Coverage for Experimental Technologies
- 1 January 1995
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 14 (4) , 143-158
- https://doi.org/10.1377/hlthaff.14.4.143
Abstract
As the number and cost of new technologies grow, it is increasingly important that we develop sound policies for payment for those technologies while their clinical impacts are being defined. Such policies need to balance social interests in promotion of innovation, early access to promising technology, patient safety, control of health care costs, and return on investment. We present a rationale, policy options, and a proposal for insurance coverage of experimental technology.Keywords
This publication has 4 references indexed in Scilit:
- Variation in Approval by Insurance Companies of Coverage for Autologous Bone Marrow Transplantation for Breast CancerNew England Journal of Medicine, 1994
- Criteria for Standard Versus Experimental TherapyHealth Affairs, 1994
- Appropriateness of acute medical care for the elderly: an analysis of the literatureHealth Policy, 1990
- The Federal Regulation of Medical DevicesNew England Journal of Medicine, 1987